FDA campaign H-0656-2026
Class IIHazard
May be temperature abused, which may result in growth of Clostridium botulinum
Distribution
NY and NJ
REKALLD area-alert coverage: NJ, NY (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.